Maze Therapeutics Inc (MAZE)

Oct 14, 2025

Can Maze Therapeutics Inc. stock beat market expectations this quarterM&A Rumor & AI Forecasted Stock Moves - newser.com

Oct 14, 2025

Oct 14, 2025

What is the fair value of Maze Therapeutics Inc. stock nowJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com

Oct 14, 2025

Oct 14, 2025

Why Maze Therapeutics Inc. is moving todayQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com

Oct 14, 2025

Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Can a trend reversal in Maze Therapeutics Inc. lead to recovery2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

How to use a screener to detect Maze Therapeutics Inc. breakoutsWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics Appoints Herve Hoppenot as Board Chairman - MarketScreener

Oct 06, 2025

Oct 06, 2025

What technical models suggest about Maze Therapeutics Inc.’s comeback2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as chairman of the board - Investing.com

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics Appoints Hervé Hoppenot as Chairman - TipRanks

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman - Investing.com India

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman By Investing.com - Investing.com Australia

Oct 06, 2025

Oct 06, 2025

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewswire

Oct 06, 2025

Oct 06, 2025

Detecting price anomalies in Maze Therapeutics Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025

Oct 05, 2025

Predicting Maze Therapeutics Inc. trend using moving averages2025 Top Decliners & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025

Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Current Valuation Following a 78% Monthly Share Price Surge - Sahm

Oct 04, 2025

Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Valuation After 78% 30-Day Share Price Surge - Yahoo Finance

Oct 04, 2025

Oct 04, 2025

What drives Maze Therapeutics Inc stock priceSupport Level Holds & Exceptional Profit Trading - earlytimes.in

Oct 04, 2025

Oct 02, 2025

Developing predictive dashboards with Maze Therapeutics Inc. dataWall Street Watch & Low Risk Entry Point Guides - newser.com

Oct 02, 2025

Oct 02, 2025

BTIG Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛

Oct 02, 2025

Sep 30, 2025

Maze Therapeutics Stock Just Shot Up 24% Pre-Market Today – Here’s What Happened - MSN

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Group Inc. Makes New $145,000 Investment in Maze Therapeutics, Inc. $MAZE - Defense World

Sep 30, 2025

Sep 29, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 5.2%Should You Sell? - MarketBeat

Sep 29, 2025

Sep 29, 2025

Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $37.00 at JPMorgan Chase & Co. - MarketBeat

Sep 29, 2025

Sep 29, 2025

J.P. Morgan Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Raises Target Price to $37 - 富途牛牛

Sep 29, 2025

Sep 27, 2025

What analysts say about Maze Therapeutics Inc stockEarnings Beat Highlights & Outstanding Trading Tips - earlytimes.in

Sep 27, 2025

Sep 25, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 4.4%Still a Buy? - MarketBeat

Sep 25, 2025